Dynamic change in the mitral valve tenting as a predictor of the long-term prognosis in patients with decompensated heart failure

Journal of Echocardiography

Volumn 6, Issue 1, 2008, Pages 15-20

  Obase, Kikuko ^a   Watanabe, Nozomi ^a   Yamaura, Yasuko ^a   Tsukiji, Miwako ^a   Neishi, Yoji ^a   Kawamoto, Takahiro ^a   Toyota, Eiji ^a   Okura, Hiroyuki ^a   Yoshida, Kiyoshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Congestive heart failure; Functional mitral regurgitation; Mitral valve tenting

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; INOTROPIC AGENT; VASOACTIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HUMAN; INCIDENCE; INTENSIVE CARE; KAPLAN MEIER METHOD; LONG TERM CARE; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE TENTING; MORTALITY; PROGNOSIS; RECURRENT DISEASE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

EID: 77953373770     PISSN: 13490222     EISSN: 1880344X     Source Type: Journal    
DOI: 10.2303/jecho.6.15     Document Type: Article

References (20)

1. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003; 91: 360-2.
2. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 1997; 96: 1826-34.
3. Yiu SF, Enriquez Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. Circulation 2000; 102: 1400-6.
4. Levine RA, Otsuji Y, Schwammenthal E et al. Ischemic Mitral Regurgitation: From New Understanding to New Solutions Role of Echocardiography. J Echocardiogr 2006; 4: 1-18.
5. Grigioni F, Enriquez Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001; 103:1759-64.
6. Bursi F, Enriquez Sarano M, Nkomo VT et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005; 111: 295-301.
7. Stevenson LW, Bellil D, Grover McKay M et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60: 654-8.
8. Capomolla S, Pozzoli M, Opasich C et al. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Am Heart J 1997; 134: 1089-98.
9. Watanabe N, Ogasawara Y, Yamaura Y, et al. Dynamics of Mitral Complex Geometry and Functional Mitral Regurgitation During Heart Failure Treatment. J Echocardiogr 2006; 4: 51-8.
10. O'Connor CM, Gattis WA, Shaw L, Cuffe MS, Califf RM. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 2000; 86: 863-7.
11. Pocock SJ, Wang D, Pfeffer MA et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27: 65-75.
12. Grigioni F, Detaint D, Avierinos JF, Scott C, Tajik J, Enriquez Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol 2005; 45: 260-7.
13. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 1994; 90: 2772-9.
14. Cannan CR, Reeder GS, Bailey KR, Melton LJ 3rd, Gersh BJ. Natural history of hypertrophic cardiomyopathy. A population based study, 1976 through 1990. Circulation 1995; 92: 2488-95.
15. Cohn PF, Gorlin R, Cohn LH, Collins JJ Jr. Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease. Am J Cardiol 1974; 34: 136-41.
16. Borow KM, Green LH, Mann T et al. End-systolic volume as a predictor a postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 1980; 68: 655-63.
17. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 1984; 3: 235-42.
18. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease: developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48: e1-148.
19. Enriquez-Sarano M, Tajik AJ, Schaff HV et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994; 24: 1536-43.
20. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999; 99: 1851-7.